Publication | Closed Access

A novel therapeutic combination of dapagliflozin, Lactobacillus and crocin attenuates diabetic cardiomyopathy in rats: Role of oxidative stress, gut microbiota, and PPARγ activation

InflammationMetabolic SyndromeMedicineNovel Therapeutic CombinationPhysiologyDiabetesMetabolic SignalingGut-organ AxisMetabolismDiabetes ComplicationsPparγ ActivationDiabetes MellitusIntestinal MicrobiotaPharmacologyInsulin SignalingOxidative StressHealth Sciences